Cargando…

Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)

In recent years, the cancer stem cell (CSC) theory has provided a new angle in the research of cancer, and has gradually gained significance. According to this theory, the multiple drug resistance (MDR) of cancer is most likely due to the resistance of CSCs, and a significant quantity of research ha...

Descripción completa

Detalles Bibliográficos
Autores principales: DI, CHONG, ZHAO, YAODONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280950/
https://www.ncbi.nlm.nih.gov/pubmed/25574188
http://dx.doi.org/10.3892/etm.2014.2141
_version_ 1782350923223269376
author DI, CHONG
ZHAO, YAODONG
author_facet DI, CHONG
ZHAO, YAODONG
author_sort DI, CHONG
collection PubMed
description In recent years, the cancer stem cell (CSC) theory has provided a new angle in the research of cancer, and has gradually gained significance. According to this theory, the multiple drug resistance (MDR) of cancer is most likely due to the resistance of CSCs, and a significant quantity of research has been carried out into the MDR mechanisms of CSC. Over time, some of these mechanisms have been gradually accepted, including ATP-binding cassette transporters, aldehyde dehydrogenase, the CSC microenvironment and epithelial to mesenchymal transition. In the present review, we summarize these mechanisms in detail and review possible appropriate therapy plans against CSCs based on CSC theory.
format Online
Article
Text
id pubmed-4280950
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-42809502015-01-08 Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review) DI, CHONG ZHAO, YAODONG Exp Ther Med Articles In recent years, the cancer stem cell (CSC) theory has provided a new angle in the research of cancer, and has gradually gained significance. According to this theory, the multiple drug resistance (MDR) of cancer is most likely due to the resistance of CSCs, and a significant quantity of research has been carried out into the MDR mechanisms of CSC. Over time, some of these mechanisms have been gradually accepted, including ATP-binding cassette transporters, aldehyde dehydrogenase, the CSC microenvironment and epithelial to mesenchymal transition. In the present review, we summarize these mechanisms in detail and review possible appropriate therapy plans against CSCs based on CSC theory. D.A. Spandidos 2015-02 2014-12-16 /pmc/articles/PMC4280950/ /pubmed/25574188 http://dx.doi.org/10.3892/etm.2014.2141 Text en Copyright © 2015, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
DI, CHONG
ZHAO, YAODONG
Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title_full Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title_fullStr Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title_full_unstemmed Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title_short Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
title_sort multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (review)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280950/
https://www.ncbi.nlm.nih.gov/pubmed/25574188
http://dx.doi.org/10.3892/etm.2014.2141
work_keys_str_mv AT dichong multipledrugresistanceduetoresistancetostemcellsandstemcelltreatmentprogressincancerreview
AT zhaoyaodong multipledrugresistanceduetoresistancetostemcellsandstemcelltreatmentprogressincancerreview